LENZ Therapeutics(LENZ)
SOLANA BEACH, CA
BiotechnologyFocus: Ophthalmology Treatments
LENZ Therapeutics is a life sciences company focused on Ophthalmology Treatments.
Ophthalmology
Funding Stage
PUBLIC
Open Jobs
0
Products & Portfolio (1)
Pipeline & Clinical Trials
Aceclidine + Brimonidine
Eye DiseasesClinical Trials (1)
NCT05936489Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
Phase 1LNZ101
PresbyopiaClinical Trials (1)
NCT06270030Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
Phase 1Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT05294328Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Phase 2PRX-100
PresbyopiaClinical Trials (1)
NCT02554396Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Phase 2Aceclidine+tropicamide combination
PresbyopiaClinical Trials (1)
NCT03201562A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Phase 2Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT05431543Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
Phase 2Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT05656027Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Phase 3Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT06045299Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Phase 3Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT05753189Phase 3 Safety Study for the Treatment of Presbyopia Subjects
Phase 3Aceclidine+Brimonidine combination ophthalmic solution
PresbyopiaClinical Trials (1)
NCT05728944Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 1 approved product, 10 clinical trials
SEC Filings: 2 available
Portfolio Health
Launch1 (100%)
1 total products
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 3 crawl cycles